Rare Disease Partnerships Ultragenyx targets rare and ultrarare diseases with a diverse pipeline, creating broad partnership potential across discovery, development, and commercialization. This opens opportunities for strategic alliances with CROs, CMOs, and specialty vendors to accelerate programs and expand patient access.

Gene Therapy Needs With UX111 gene therapy and UX016 IND activity, there is a clear need for specialized gene therapy manufacturing, vector supply, analytical testing, and regulatory support to meet accelerated timelines.

Regulatory & Access Recent regulatory actions and accelerated pathway considerations indicate strong demand for regulatory affairs expertise, submission readiness, and payer evidence development to enable timely approvals and market access.

Digital & Data The tech footprint including cloud platforms, LIMS, and SOC 2 compliance signals opportunities for secure data integration, cloud hosting, analytics, and regulatory-grade data management services to support trials and manufacturing.

Regional Growth Headquartered in Northern California with a sizable, diverse workforce and a patient-centric culture, Ultragenyx offers regional collaboration opportunities, co development discussions, and access to a robust ecosystem for research partnerships and talent development.